Key Insights

Highlights

Treatment Research

2 treatments under study, led by Surgical Operation

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1
Enrolling By Invitation1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07905300Enrolling By Invitation

Intestinal Obstruction Surgery. Acute Abdominal Pathology. №9:05/05/2026

NCT00778479Not ApplicableTerminatedPrimary

Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

Showing all 2 trials

Research Network

Common Treatments

  • Surgical Operation1
  • Sepraspray1

Active Sponsors

  • Genzyme, a Sanofi Company1
  • Astana Medical University1

Top Investigators

Related Conditions

  • Laparoscopic Abdominal Surgeries1
  • Adhesiolysis1
  • Small Bowel Adhesion1
  • Laparotomy Patients1
  • Obstruction Bowel1

Activity Timeline